Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
QuidelOrtho Corporation - Common Stock
(NQ:
QDEL
)
35.60
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about QuidelOrtho Corporation - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
December 22, 2021
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.
Via
Talk Markets
COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests
December 21, 2021
President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to...
Via
Benzinga
QDEL Stock Alert: What Is Going on With Quidel Today?
December 20, 2021
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result.
Via
InvestorPlace
Quidel Announces Sponsorship and Community Partnership With the Chicago Blackhawks
December 15, 2021
From
Quidel Corporation
Via
Business Wire
Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease
December 14, 2021
From
Quidel Corporation
Via
Business Wire
Biotech Playbook 2021: No Help From Small Caps In Q4
December 14, 2021
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...
Via
Talk Markets
7 Stocks to Buy to Hedge Against Omicron Variant Risks
December 13, 2021
With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
December 06, 2021
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD
Via
Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
December 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Quidel Statement on the Omicron Variant
November 30, 2021
From
Quidel Corporation
Via
Business Wire
Biotech Stocks are Due for a Rally
November 22, 2021
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.
Via
Talk Markets
Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference
November 19, 2021
From
Quidel Corporation
Via
Business Wire
Looking for Growth in Small and Mid Cap Life Science Stocks
November 15, 2021
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.
Via
Talk Markets
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
November 09, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced...
Via
FinancialNewsMedia
Exposures
COVID-19
Quidel Corp (QDEL) Q3 2021 Earnings Call Transcript
November 05, 2021
QDEL earnings call for the period ending October 4, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Quidel Reports Third Quarter 2021 Financial Results
November 04, 2021
From
Quidel Corporation
Via
Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
November 02, 2021
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
Via
News Direct
Exposures
COVID-19
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
November 02, 2021
From
Quidel Corporation
Via
Business Wire
Quidel to Hold Fiscal Third Quarter 2021 Financial Results Conference Call on November 4th, 2021
October 20, 2021
From
Quidel Corporation
Via
Business Wire
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead
October 20, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 20, 2021 – USA News Group – It may have its beginning for the UK travel industry, but there are signs of the end of using...
Via
FinancialNewsMedia
Exposures
COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Pediatric Lyme Disease—‘An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
October 18, 2021
From
Quidel Corporation
Via
Business Wire
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
October 18, 2021
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
Via
News Direct
Exposures
COVID-19
Product Safety
Quidel Blows Past Estimates for Q3 Revenue
October 14, 2021
COVID-19 testing volumes are up again.
Via
The Motley Fool
Exposures
COVID-19
Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected
October 08, 2021
Quidel Corporation (NASDAQ: QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19 assay sales. Related:...
Via
Benzinga
Exposures
COVID-19
After the Jobs Report, Investors are Looking at The Fed for Tapering Signals
October 08, 2021
Investors were in wait-and-see mode before the Employment Situation Report and then the volatility hit. Non-farm job growth was expected to be around 500,000...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Data
October 08, 2021
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade ahead of the all-important jobs report for the month of September. Analysts expect nonfarm...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.